ArticleJMIR bioinformatics and biotechnology2025
Framework for Race-Specific Prostate Cancer Detection Using Machine Learning Through Gene Expression Data: Feature Selection Optimization Approach.
Article in JMIR bioinformatics and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal feature-optimized approaches for cancer classification using microarray gene expression analysis.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous machine learning approaches for prostate cancer detection using gene expression data have shown remarkable classification accuracies. However, prior studies overlook the influence of racial diversity within the population and the importance of selecting outlier genes based on expression profiles. Objective: We aim to develop a classification method for diagnosing prostate cancer using gene expression in specific populations. Methods: This research uses differentially expressed gene analysis, receiver operating characteristic analysis, and MSigDB (Molecular Signature Database) verification as a feature selection framework to identify genes for constructing support vector machine models. Results: Among the models evaluated, the highest observed accuracy was achieved using 139 gene features without oversampling, resulting in 98% accuracy for White patients and 97% for African American patients, based on 388 training samples and 92 testing samples. Notably, another model achieved a similarly strong performance, with 97% accuracy for White patients and 95% for African American patients, using only 9 gene features. It was trained on 374 samples and tested on 138 samples. Conclusions: The findings identify a race-specific diagnosis method for prostate cancer detection using enhanced feature selection and machine learning. This approach emphasizes the potential for developing unbiased diagnostic tools in specific populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.